(PharmaNewsWire.Com, September 13, 2018 ) Breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, & Rest of the World. In 2016, North America is estimated to dominate breast imaging market, majorly due to rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players.
Key players operating in breast imaging market Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.).
Executive Summary
1 Introduction
2 Current Scenario
3 Future Outlook
4 Conclusion
Premium Insights
1 Breast Imaging Market Overview
2 Breast Imaging Market Share, By Type, 2016 vs. 2021
3 Geographic Analysis: Ionizing Technologies Market, By Type
4 Geographic Analysis: Non-Ionizing Technologies Market, By Type (2016)
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Molecular Breast Imaging/Breast-specific Gamma Imaging (MBI/BSGI)
Cone-beam Computed Tomography (CBCT)
Positron Emission Mammography (PEM)
Electric Impedance Tomography
Click now for more Details, Quiries and Discount and Other Information on this study Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021 report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=68046 .
Global breast imaging market segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
